Registration number: 07964805

Brunlea Surgical Supplies Limited

Contents

Statement of Financial Position	1 to 2
Notes to the Unaudited Financial Statements	3 to 9

Brunlea Surgical Supplies Limited

(Registration number: 07964805)
Statement of Financial Position as at 31 May 2025

	Note	2025 £	2024 £
Fixed assets
Intangible assets	4	990,208	1,112,708
Tangible assets	5	118,352	41,366
Other financial assets	6	525,293	482,807
		1,633,853	1,636,881
Current assets
Stocks		298,000	250,259
Debtors	7	649,300	753,039
Cash at bank and in hand		1,677,693	2,419,089
		2,624,993	3,422,387
Creditors: Amounts falling due within one year	8	(1,069,470)	(1,642,295)
Net current assets		1,555,523	1,780,092
Total assets less current liabilities		3,189,376	3,416,973
Provisions for liabilities		(29,588)	(9,966)
Net assets		3,159,788	3,407,007
Capital and reserves
Called up share capital		1,150,100	1,650,100
Retained earnings		2,009,688	1,756,907
Shareholders' funds		3,159,788	3,407,007

For the financial year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Income Statement .

Brunlea Surgical Supplies Limited

(Registration number: 07964805)
Statement of Financial Position as at 31 May 2025

Approved and authorised by the Board on 30 September 2025 and signed on its behalf by:
 

Mrs C Bullock Director

Brunlea Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
138a Casterton Avenue
Burnley
Lancashire
BB10 2PE

These financial statements were authorised for issue by the Board on 30 September 2025.

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Judgements and Key Sources of Estimation Uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

In the opinion of the directors there are no critical accounting judgments.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Brunlea Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Alterations to leasehold premises	10% straight line
Plant and machinery	15% straight line
Fixtures, fittings & equipment	15% straight line
Computer equipment	25% straight line
Motor vehicles	20% straight line

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Goodwill	5% straight line

Investments

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Brunlea Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in the profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
 

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 12 (2024 - 12).

Brunlea Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

4	Intangible assets

	Goodwill  £	Total £
Cost or valuation
At 1 June 2024	2,450,000	2,450,000
At 31 May 2025	2,450,000	2,450,000
Amortisation
At 1 June 2024	1,337,292	1,337,292
Amortisation charge	122,500	122,500
At 31 May 2025	1,459,792	1,459,792
Carrying amount
At 31 May 2025	990,208	990,208
At 31 May 2024	1,112,708	1,112,708

The goodwill arose on the purchase of the trade and certain assets of Brunlea Surgical Supplies on 1 July 2013 and is being amortised over its estimated useful economic life of 20 years.

5	Tangible assets

	Short leasehold £	Furniture, fittings and equipment  £	Motor vehicles  £	Total £
Cost or valuation
At 1 June 2024	30,924	226,992	-	257,916
Additions	-	6,195	85,000	91,195
At 31 May 2025	30,924	233,187	85,000	349,111
Depreciation
At 1 June 2024	30,924	185,626	-	216,550
Charge for the year	-	11,376	2,833	14,209
At 31 May 2025	30,924	197,002	2,833	230,759
Carrying amount
At 31 May 2025	-	36,185	82,167	118,352
At 31 May 2024	-	41,366	-	41,366

Brunlea Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

6	Other financial assets (current and non-current)

	Financial assets at fair value through profit and loss £	Total £
Non-current financial assets
Cost or valuation
At 1 June 2024	482,807	482,807
Fair value adjustments	18,486	18,486
Additions	24,000	24,000
At 31 May 2025	525,293	525,293
Impairment
At 31 May 2025	-	-
Carrying amount
At 31 May 2025	525,293	525,293
At 31 May 2024	482,807	482,807

7

Debtors

Current	2025 £	2024 £
Trade debtors	633,435	737,484
Prepayments	15,615	13,785
Other debtors	250	1,770
	649,300	753,039

Brunlea Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

8

Creditors

Creditors: amounts falling due within one year

	2025 £	2024 £
Due within one year
Trade creditors	546,738	503,265
Taxation and social security	221,002	257,844
Accruals and deferred income	9,175	14,299
Other creditors	292,555	866,887
	1,069,470	1,642,295

9	Related party transactions

During the period the company operated loan accounts with its directors and close family members. The amounts owed in respect of these loans at the year end was was £293,056 (2024:£365,083). The loans are interest free and there are no set dates of repayments.

Brunlea Surgical Supplies Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 May 2025

10	Non adjusting events after the financial period

Subsequent to the year-end, the company repurchased 30 B ordinary shares on 24 August 2025 for £715,661. The repurchased shares have been cancelled. This transaction does not affect the financial position at 31 May 2025.